Top Markets
Coin of the day
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.

Silverback Therapeutics, Inc.

SBTX
Hisse Senetlerindeki Sıralama #12775
Silverback Therapeutics, Inc. operates as a biotechnology firm dedicated to... Silverback Therapeutics, Inc. operates as a biotechnology firm dedicated to devising tissue-specific drug candidates aimed at addressing chronic viral infections, various cancers, and other significant medical conditions. Among its pipeline, SBT8230 stands out as a treatment for chronic hepatitis B virus, working by stimulating an antiviral immune response through the precise activation of TLR8 within the liver. The company was founded in 2016 and maintains its principal offices in Seattle, Washington.
Hisse Fiyatı
$5.87
Son senkronizasyon: 2022-11-08
Piyasa Değeri
$550.43M
Değişim (1 gün)
1.03%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Silverback Therapeutics, Inc. (SBTX)

Kategori

B piyasa değeri ile SBTX fiyatı
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
SBTX
$5.87
Piyasa Değeri Silverback Therapeutics, Inc.(SBTX)
Piyasa Değeri: $550.43M
August 2026 itibarıyla Silverback Therapeutics, Inc. şirketinin piyasa değeri $550.43M. Bu, verilerimize göre Silverback Therapeutics, Inc. şirketini dünyanın en değerli 12775th. şirketi yapar. Piyasa değeri, halka açık bir şirketin tedavüldeki hisse senetlerinin toplam piyasa değeri olup, bir şirketin değerini ölçmek için yaygın olarak kullanılır.
Silverback Therapeutics, Inc. piyasa değeri geçmişi (2020 - 2026)
En Popüler 5 stocks ile karşılaştırıldığında SBTX
SBTX’in Fiyatı B Varlığı B’nin Piyasa Değeri Sonuçlar
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
$56,135.85 $550.43M
$5.264T +956,217.67%
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
$50,136.16 $550.43M
$4.701T +854,008.32%
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
$44,546.98 $550.43M
$4.177T +758,792.33%
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
$40,710.19 $550.43M
$3.817T +693,429.61%
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
$30,567.68 $550.43M
$2.866T +520,644.20%